2011
Strategic planning is long overdue and could mitigate long-term complications that result from delayed diagnosis of primary ovarian insufficiency
Seifer DB. Strategic planning is long overdue and could mitigate long-term complications that result from delayed diagnosis of primary ovarian insufficiency. Fertility And Sterility 2011, 95: 1898. PMID: 21444076, DOI: 10.1016/j.fertnstert.2011.03.008.Peer-Reviewed Original Research
2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
Seifer DB, MacLaughlin DT. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertility And Sterility 2007, 88: 539-546. PMID: 17559842, DOI: 10.1016/j.fertnstert.2007.02.014.Peer-Reviewed Original ResearchConceptsPolycystic ovarian diseaseMullerian Inhibiting SubstanceOvarian reserveOvulation inductionInhibiting SubstanceDiagnosis of PCODRisk of OHSSOvarian growth factorsWidespread clinical useOvarian hyperstimulationOvarian diseaseOvarian functionMEDLINE reviewClinical significanceIntracycle variabilityEarly markerClinical useConventional markersDiagnostic markerGrowth factorSpecific cutIntercycle variabilityDifferent assaysMarkersDiagnosis
1995
Laparoscopic management of ectopic pregnancy
Grainger D, Seifer D. Laparoscopic management of ectopic pregnancy. Current Opinion In Obstetrics & Gynecology 1995, 7: 277-282. PMID: 7578967, DOI: 10.1097/00001703-199508000-00009.Peer-Reviewed Original ResearchConceptsEctopic pregnancySerum beta-human chorionic gonadotropinBeta-human chorionic gonadotropinPersistent ectopic pregnancyUse of methotrexateAlgorithm of diagnosisInvolved tubeLaparoscopic managementSurgical managementTransvaginal ultrasoundLocal injectionChorionic gonadotropinEarly diagnosisHigh indexPregnancyDiagnosisPatientsSurgeryGonadotropinMethotrexateManagementSuspicion